chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Nausea; Headache; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, the patient experienced DIZZINESS (Dizziness). 01-Jun-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, DIZZINESS (Dizziness), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.
Muscle ache; Redness; Allergy; Blurry vision; Dry mouth,Getting a fungus; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision), DRY MOUTH (Dry mouth,Getting a fungus), MYALGIA (Muscle ache) and ERYTHEMA (Redness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event. Concomitant products included CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and Blood pressure medication for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision) and DRY MOUTH (Dry mouth,Getting a fungus). On 09-May-2021, the patient experienced MYALGIA (Muscle ache) and ERYTHEMA (Redness). At the time of the report, HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision), DRY MOUTH (Dry mouth,Getting a fungus), MYALGIA (Muscle ache) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment with Tylenol was provided pertained to the symptoms experienced.
Purple on stomach, loose teeth, large peeling skin on butt... was given starroides  Outcome.. ptsd 70% service connection.
BODY ACHES; SHORTNESS OF BREATH; TIREDNESS; SWEATY AROUND HIS NECK AREA, PERSPIRING  FROM BACK AND SHOULDER AREA, FELT WATER COMING THROUGH THE BACK; WAKING UP IN THE MORNING; This spontaneous report received from a consumer concerned a 43 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient has been working outdoor for many year, he was not one of those people that sweat that much, he never experienced such events before vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 20-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-SEP-2021, the patient experienced sweaty around his neck area, perspiring from back and shoulder area, felt water coming through the back. On 07-SEP-2021, the patient experienced waking up in the morning. On an unspecified date, the patient experienced body aches, shortness of breath, and tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, shortness of breath, and tiredness, and had not recovered from sweaty around his neck area, perspiring from back and shoulder area, felt water coming through the back, and waking up in the morning. This report was non-serious.
Big red mark with swelling at injection site 4-5 inches in length, 2-3 in width. Feels warm to touch. Itchy when it first appeared, no itchiness about 10 hours later
About an hour and a half after receiving the first vaccine, my ears starting ringing pretty loudly and they haven't stopped. If I am outside near a lawn mower or stopped near a motorcycle at a traffic light, I can hear the ringing over them. The ringing is accompanied by heightened noise sensitivity. Also, a few hours after the ringing started, mild arthritis kicked in.   Almost 20 years ago, I had a mystery illness that triggered many symptoms including mild tinnitus and painful arthritis. I had a borderline positive Lyme test and took two rounds of antibiotics without improving. Rheumatologist thought it might be virus related. After many months most symptoms went away, though constant mild tinnitus has persisted.
Covid19 breakthrough.  1st vaccine received on 03/02/2021.  84 y/o with PMHX of AS,CHF,Pacemaker, DM, COPD, HTN, HLD, mod AS, Pulm emboli/dvt presents with 4 day hx of CP and worsening SOB.  Started on low dose steroids.
A report has been received from a Health Professional concerning a 1 year old, Female subject, who has been receiving Nasal FLUMIST. FLUMIST started on 21-DEC-2012. The Health professional reported that, 18 month old patient received FLUMIST on 21-DEC-2012. The outcome of the event of 18 month old received FLUMIST is unknown. The report was considered to be non-serious.
dx w/SSPE AUG98;sick for over year myoclonic jerks, unable to eat, dress unassisted, mental deterioration, has had neurosurgery;
Hives and urticaria at injection site eight days after dosage, followed by breakouts on other parts of the body.
Booster; Off label use; Bruising, redness under her armpit and on left breast; Redness under her armpit and on left breast; Chills; Fatigue; Sore under armpit; This is a spontaneous report from a non-contactable healthcare professional. A 38-year-old female patient received the third dose (BOOSTER DOSE) of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on 24Sep2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 24Sep2021, the patient experienced bruising, redness under her armpit and on left breast and soreness under her armpit. On 24Sep2021, she also started to experience chills and fatigue. As of 28Sep2021, she was still sore under her armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL) every 6 hours and ibuprofen (MOTRIN) along with using a hot compress. The clinical outcome of the events bruising, redness under her armpit and on left breast, chills and fatigue, sore under armpit was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
at night woke up to go to the bathroom and almost felt; They don't know if they should take a Xanax or not, because they feels like they are having an anxiety atack; face is a little bit red; fells hot, forehead is warm; their hand are frizzing cold.; chills; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (at night woke up to go to the bathroom and almost felt), ANXIETY (They don't know if they should take a Xanax or not, because they feels like they are having an anxiety atack), ERYTHEMA (face is a little bit red), FEELING HOT (fells hot, forehead is warm) and PERIPHERAL COLDNESS (their hand are frizzing cold.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history information was reported.  Concomitant products included METFORMIN, VALSARTAN, ALLOPURINOL, APIXABAN (ELIQUIS), AMLODIPINE, ATORVASTATIN, METOPROLOL and DULAGLUTIDE (TRULICITY) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced PRESYNCOPE (at night woke up to go to the bathroom and almost felt), ANXIETY (They don't know if they should take a Xanax or not, because they feels like they are having an anxiety atack), ERYTHEMA (face is a little bit red), FEELING HOT (fells hot, forehead is warm), PERIPHERAL COLDNESS (their hand are frizzing cold.) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, PRESYNCOPE (at night woke up to go to the bathroom and almost felt), ANXIETY (They don't know if they should take a Xanax or not, because they feels like they are having an anxiety atack), ERYTHEMA (face is a little bit red), FEELING HOT (fells hot, forehead is warm), PERIPHERAL COLDNESS (their hand are frizzing cold.) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient took blood pressure medications
The area just under the injection site has become red, swollen and inflamed and is about the size of closed fist (2"x3").  What has been termed "vaccine arm".
This is a serious literature case, initially received on 29-Apr-2019, concerning an adult female patient of an unspecified age (reported as middle-aged healthy woman). The objective of the article was that a variety of environmental risk factors can trigger the onset of rheumatic disorders. Vaccines stand next to antibiotics as a nineteenth-century medical breakthrough impacting the human evolution and survival. Evidently, an age-old process of conferring immunity without active infection, practiced in civilizations, introduced and advocated in modern medicine at the time of renaissance by prominent  physicians. Vaccines tend to stimulate both the humoral and cellular immunity depending on the type of antigenic stimulation. As with any other medical-intervention, even vaccines sometimes result in adverse events. Vaccine-related side effects were increasing exponentially with higher availability, awareness, and reporting. The patient's current condition included palindromic rheumatism since an unspecified date for which the patient was being treated. On an unspecified date, the patient was administered INN Flu Vaccine Seasonal [dose: 0.5 ml (reported as standard dose), route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported] for an unknown indication. On an unspecified date after vaccination (reported as close proximity to immunization), the patient developed rheumatoid arthritis. It was reported that the disease remained chronic, required continuous standard treatment. The outcome of the event was not reported. It was reported that the vaccine-induced auto-immune disease may have atypical presentation when compared to the idiopathic origin counterpart and this might direct to-wards slightly altered pathologic mechanisms directed at vaccine-related phenomena (related). This case (201903241) is second of the 3 cases linked due to same reporter (author). The reporter concluded that although no strong evidence exists to contraindicate vaccinations, even in patients with existing autoimmune conditions, though the immune response if not as strong as in normal individuals, the benefits granted for routine vaccination. There might be a special group of the population with more predisposition to vaccine-related adverse effects, and only with more epidemiologic data and physician awareness and reporting, they might be able to find the at-risk groups and lower the incidence.; Reporter's Comments: An adult female patient of unknown age with current condition (palindromic rheumatism) developed rheumatoid arthritis, after administration of INN Flu Vaccine (reported as close proximity to immunization). Considering the plausible temporal relationship between vaccination and reported event and lack of any underlying conditions or alternative more plausible causes, the company conservatively assessed the event as possibly related to suspect vaccine. The company assessed the event 'rheumatoid arthritis' as serious (medically significant).
12/10/21: The patient presents with cough. 70 y/o male presents to the ED c/o cough x 2 weeks ago. Per pt, he started having fatigue, cough, and decreased appetite 2 weeks ago. His wife at home has similar symptoms as well. He visited urgent care on the 30th and was prescribed Zithromax, but symptoms did not improve so went back on the 3rd, had his abx switched to Augmentin but symptoms stayed the same. Pt is vaccinated against COVID-19 with 2 doses of the Pfizer vaccine. Notes he tested negative for the Flu on the 3rd and tested negative for COVID-19 last week. However symptoms are not improving so is here today, otherwise denies any CP, nausea, vomiting, onset was 2 weeks ago.
The patient experienced substantial arm pain after vaccination; This spontaneous report as received from a pharmacist referring to a 72-year-old male patient. The patient's pertinent medical history was unknown by reporter. His drug reactions or allergies included gentamicin and neomycin, and his concomitant therapies included oxybutynin, tadalafil, propranolol hydrochloride, hydrochlorothiazide, tizanidine hydrochloride and primidone.      On 20-NOV-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) at a dose of 0.5 milliliter, intramuscular for prophylaxis (strength and anatomical location were not reported, lot # T017385 had been verified to be a valid number; expiration date 01-SEP-2021).      On 20-NOV-2020, the patient experienced substantial arm pain for an extended period of time (pain in extremity). His arm was sore for about 3 days following vaccination and he was recovered. The pharmacist stated that they give a lot of the vaccine and have never had people complain about the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) being so painful after administration.   The causality assessment between pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) and the aforementioned event not provided.     This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2012USA006575:
admitted to Hospital 8/31/2021 with weakness and mild cough. Found to be COVID (+). Daughter stated that her hospitalization was due to COVID and a number of things but didn't elaborate. ROom air, no ICU stay. Transferred to Inpatient Rehab currently
Patient reported a red and swollen arm after receiving her pneumonia shot.  Patient went to urgent care for treatment.  She was given cephalexin to  treat   swelling.  She received the shot October 6th and went to urgent care on October 8th.  Patient reported the incident to me October 11th. I inspected the area and saw no redness or swelling.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding the medical history, drug reactions/allergies and concurrent conditions was not reported. On 11-APR-2018, the patient was vaccinated with an improperly stored dose of Oka/Merck VARIVAX subcutaneously, lot # N013277, expiration date: 28-APR-2019 (dose and site of administration were not reported) for prophylaxis. It was stored in temperature of 6 Fahrenheit degrees (F) to 14 F (7.9 F) for 19 minutes. There was no previous temperature excursion. The call was a result of a reading from a Digital Data Logger. The nurse reported that the diluent (lot number and expiration date were unknown) used to reconstitute the Oka/Merck VARIVAX was properly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1805USA003480: US-009507513-1805USA003481: US-009507513-1805USA003482: US-009507513-1805USA003483: US-009507513-1805USA002990.
Itchy rash began to develop on my scalp, face, back of neck, and upper arms on Friday evening, 9/23/22.  Woke up Saturday morning to a swollen rash on the left side of my face around my temple and eye area.  More rash spots appeared and were very itchy on my torso and hips.  I went to an urgent care facility late Sunday afternoon, received a steroid shot in my right hip, and was given a prescription for Prednisone 20mg pills to take over the next several days.  Treatment was moderately successful until the next Saturday, 10/1/22, until the dosages of the Prednisone and Benedryl allergy pills were reduced and the condition flared back up.  I made an appointment with my PCP FNP, on Monday, 10/3/22, and was prescribed Hydroxyzine HCL 25 mg tablet and Betamethasone 0.1% cream.  I began that new course of medicine Monday 10/3/22 night and again today.  Rash areas are changing to appear more rounded in shape.
The immunization was administered at 2:00 pm on 9/22/18.  At around 4:00 pm on 9/22, she started experiencing an unsettled stomach and diarrhea.  She didn't feel well throughout the weekend and followed up with her PCP on Monday, 9/24/2018.  At this point, her arm was swollen and she was severely dehydrated due to the diarrhea.  Her doctor is treating her with Keflex and Prednisone for cellulitis and she has been instructed to drink fluids for dehydration.  She was able to go back to work on 9/27/2018.
Major symptoms are plugged/whooshing/ringing/popping ears.  Pressure in my head. Dizziness, especially when I look up after looking down at my phone. My hands and feet get so cold they hurt.  I can put my frozen feet by my space heater and they don?t warm up, they just hurt more.  Inability to concentrate and foggy brain.  During  meetings I find myself starting sentences but I can?t finish them, it?s like I stop and wait for my friends/family/coworkers to finish my thoughts.   Other symptoms that don?t bother me as much. Constant sinus drainage and occasional sneezing. Dehydration.  Insomnia and vivid dreams.
COLOR CHANGE AND ASHED SKIN; CRAMPS CALF; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced cramps calf. On an unspecified date, the subject experienced color change and ashed skin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cramps calf and color change and ashed skin was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
A report has been received from a Health Professional concerning a patient, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent started on 05-Mar-2015. The patient was administered FLUMIST twice this month. The outcome of the event of administered FLUMIST twice this month is unknown. The report was considered to be non-serious.
2nd toe became painful, red and burning.  After 30 minutes pain subsided and then toe turned purple.  It stayed purple for about 2 weeks.  I don't remember if it was the left or right foot.  4 weeks later, the identical  thing happened again to the second toe on my left foot.
Sciatic nerve pain progressed to pain in legs and arms in a matter of hours. Tingling/numb feeling in feet and hands developed during this time also. Joint pain increased until Monday 11/9/09. No fever. Symptoms seemed to plateau at this point. Then decreased progressively throughout the week. As of 11/13/09 all symptoms are gone except weakness in forearms and hands. Wrists are very sore. It feels as if I had been swinging a hammer with both arms for days.
Patient will be admitted to hospitalist for hypoxia related to COVID-19 infection. Patient is a relatively healthy 60-year-old male normally seeks cares.  has been vaccinated not yet received his booster.  Complains of approximately 9-10 days of diffuse viral symptoms including myalgias, cough, nausea, vomiting, and diarrhea.  Has not been keeping up with his fluids.  The last 2-3 days he has noted increasing shortness of breath with activity.  No abrupt changes.  Denies chest pain, pleuritic pain, abdominal pain.   On evaluation in the emergency department patient was found to be hypoxic requiring supplemental oxygen.  Labs showed elevated CRP of 12.0, slightly increased creatinine at 1.36, mildly elated D-dimer of 1235, normal white blood cell count mildly elevated procalcitonin.  COVID positive 12/27/2021.  Patient was given dexamethasone and admitted for further cares.
Information was received on 03-JUL-2017 from a 70 year old female patient with allergies to KEFLEX, BACTRIM, penicillin, cephalosporin and clindamycin. Patient reported that she received ZOSTAVAX vaccine (dosage, lot#/expiration not reported) in December 2009 and she now has "shingles" (onset reported as 26-JUN-2017). The patient was prescribed by her physician valacyclovir and prednisone for her treatment of shingles. Outcome of shingles was not reported. No further adverse event information provided. The patient requested to be reimbursed for the medical expenses she accrued for her treatment of shingles. Additional information has been requested.
Pain, soreness, difficulty lifting arm that started the day of the vaccine. Applied heating pad but  it only helped a little.
This case was reported by a consumer via call center representative and described the occurrence of swollen mouth in a female patient who received BOOSTRIX. On an unknown date, the patient received BOOSTRIX (unknown). On an unknown date, 2 min after receiving BOOSTRIX, the patient experienced swollen mouth. On an unknown date, the outcome of the swollen mouth was unknown. It was unknown if the reporter considered the swollen mouth to be related to BOOSTRIX. Additional information received: A patient reported that she received a whooping cough shot 2 or 3 years ago. When asked if she received pertussis, the patient confirmed. To her knowledge she had just received pertussis by itself. Within less than 2 minutes of receiving the whooping cough shot she experienced a reaction where her mouth was swollen. The patient wondered whether it was because the shot had a rubber latex tip on the end.